Journal
Blood Advances
Publication Date
1-27-2026
Volume
10
Issue
2
First Page
343
Last Page
355
Document Type
Open Access Publication
DOI
10.1182/bloodadvances.2025017296
Rights and Permissions
Dyer MR, Zheleznyak A, Teubner EN, Prior JL, Manion B, Jing Z, Sharma AK, Du J, Tang R, Fiala MA, DiPersio JF, Veis D, O'Neal J, Berezin MY, Shokeen M. Ablation of CD38 in multiple myeloma cells leads to an aggressive phenotype in a mouse xenograft model. Blood Adv. 2026 Jan 27;10(2):343-355. doi: 10.1182/bloodadvances.2025017296. © 2026 American Society of Hematology. Published by Elsevier Inc. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.
Recommended Citation
Dyer, Michael R; Zheleznyak, Alex; Teubner, Erin N; Prior, Julie L; Manion, Brad; Jing, Zhenghan; Sharma, Amit K; Du, Junwei; Tang, Rui; Fiala, Mark A; DiPersio, John F; Veis, Deborah; O'Neal, Julie; Berezin, Mikhail Y; and Shokeen, Monica, "Ablation of CD38 in multiple myeloma cells leads to an aggressive phenotype in a mouse xenograft model." Blood Advances. 10, 2. 343 - 355. (2026).
https://digitalcommons.wustl.edu/oa_4/6416
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
